Trade Vir Biotechnology ^VIR

Vir Biotechnology (NASDAQ:VIR) Trading Down 10.4% - What's Next?

Vir Biotechnology Receives Buy Rating: Promising TCE Programs and Strategic Focus Boost Growth Outlook

Vir Biotechnology (NASDAQ:VIR) Shares Down 10.4% - Here's Why

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Vir Biotechnology (NASDAQ:VIR) Stock Price Down 10.4% - Here's What Happened

Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Edgewise Therapeutics (EWTX) and Avadel Pharmaceuticals (AVDL) | Markets Insider

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Vir Biotechnology (VIR) | Markets Insider

Vir Biotechnology (NASDAQ:VIR) Hits New 1-Year High on Analyst Upgrade

Vir Biotechnology (NASDAQ:VIR) Earns "Buy" Rating from HC Wainwright

Vir Biotechnology Announces Positive Phase 1 Clinical Data for Dual Masked T-Cell Engagers

Vir Biotechnology (NASDAQ:VIR) Hits New 52-Week High - Time to Buy?

Morgan Stanley upgrades Vir Biotechnology to 'overweight,' raises PT to $20 By Investing.com

Insider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) Director Sells 10,960 Shares of Stock

Morgan Stanley lifts Vir Biotech stock rating, doubles price target By Investing.com

VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates - January 9, 2025 - Zacks.com

Vir Biotechnology's Early Promise in Clinical Trials Warrants Hold Rating Amid Uncertainties

Vir Biotechnology's Early Stage Developments and Valuation Lead to Hold Rating Amid Long-Term Promise and Near-Term Uncertainties

Vir Biotechnology price target raised to $14 from $10 at JPMorgan

Goldman Sachs maintains Buy on Vir Biotechnology stock, $28 target By Investing.com

Vir Biotechnology (NASDAQ:VIR) Trading Up 7.1% - What's Next?

JPMorgan raises Vir Biotechnology stock target to $14 By Investing.com

Vir Biotechnology's Promising TCE Oncology Assets Earn Buy Rating from Joseph Stringer

Vir Biotechnology director Vicki L. Sato sells $137,219 in stock By Investing.com

Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - What's Next?

Vir Biotechnology stock hits 52-week high of $13.18 By Investing.com

Vir Biotechnology Reports Encouraging Phase 1 Data For Two Cancer Drug Candidates; Stock UP

Vir Biotechnology stock soars on promising trial data By Investing.com

Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC | Morningstar

Early data validate Vir's newly acquired dual-masked TCE therapies | BioWorld

Vir Biotechnology (NASDAQ:VIR) Trading 7.1% Higher - What's Next?

State Street Corp Has $42.14 Million Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Sold by Y Intercept Hong Kong Ltd

Forex Prop Trading Updates and Income Levels' Impact on Forex

Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK

S&P 500 and Nasdaq 100 Update: Strong Earnings Drive Market Gains

Oil price today: Oil Prices Climb Amid Supply Fears

Forex market update: GBP/USD, USD/JPY Forecast

Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration

Why Is the Stock Market Going Down Today and Are Interest Rates Going Down?

What Influences the Price of Heating Oil Per Gallon Today? Insights on Futures Contract Crude Oil